Chi Yao-jin He-Ail Khao-Haw Chapter of the Chi Yao-jin He-Haw Medical New Product Exhibition success
Scientific nutrition, active health is becoming increasingly a consensus, and it provides a useful reference for daily health management. On August 22, the Inhealth Group held a new product launch event at the Lord of the Rings Violin Port in Hangzhou. This event was organized not only by the concentrated results of Inhealth's many years of technological research and development, but also by the branded enterprises covering the research and development of clinical practices and the full-dimensional healthcare industry ecosystem, steadily moving from the strategic blueprint to the real world.
Several key innovations such as nano-second knife smelting technology, IgA flu vaccine innovation, amino acid enrichment powder, and others were featured, and a team of industry experts, partners and medical peers from across the country gathered to witness the key transitions in the path of technological commercialization of the Innovable Medical Group. At this conference, the three core achievements synchronised the three core avenues, covering oncology micro-diagnosis, acute pathology, precise nutritional intervention, and fully highlighted the technological integration and clinical transformation power of the multi-disciplinary field of Inhernia Medicine. The technology is based on the principle of irreversible electrical perforation, and through high-pressure ultra-short electrical pulses forms nanoscale permanent pores on the membrane of the tumor cells, which accurately induce tumor cell death.
In the field of cancer clinics, Inhealth Medical has officially introduced nanosecond knife melting technology. Currently, the technology has been completed in many domestic medical institutions in high-risk areas of cancer clinical practice surgical treatment, clinical practice is widely recognized in the professional field. As one of the world's most common congenital macular degeneration, clinical practice for the diagnosis of IgA macular degeneration has a long-standing unmet clinical need.
In the field of macular degeneration clinicology, the Director of Internal Medicine, Dr. Zhou Shenyang, affiliated to the University of Ningbo, brought innovative IgA macular degeneration antibody results. In the field of health management, the co-founder of Inhealth Medical Group, and the Dean of the School of Medicine, Dr.
Ho Pre-Spring, gave an in-depth explanation of the amino acid enrichment powder and RT respiratory health triangulation intervention system, introducing the two major achievements in the multi-use scenario of precise nutritional intervention and respiratory health management, providing more targeted professional solutions for the daily health management of people of all ages. The release of this innovative antibody targeted for reproduction induced couplets (APRIL) by selectively combining and suppressing APRIL activity, lowering the level of pathogenic immunoglobulin A from above, reducing the deposition of immune complexes in the urine, marks the move of IgA immunotherapy from formally controlling support to a new stage. It is anticipated that with technological progress and the upgrading of demand, this field will also open up new space for development.
The strategic development logic for the upgrading of the vaccine, from the accurate melting of tumors to the clinical treatment of epilepsy, to the accurate daily health interventions, and the continuous improvement of the matrix of hemp medical products is becoming clearer. The strategic development logic for the upgrading of the vaccine, driven by technological innovation and clinical practice services, is becoming clearer. At the strategic planning level, the director of hemp medicine, Jun Jun Jun, shared the strategic concepts of the membership system and the industrial ecology, and proposed a precise membership reservation service system to address the different physical conditions and health needs of individuals, providing personalized and differentiated medical health services.
From top-level strategic planning to terminal operations, from capital-added empowerment to the construction of in-house clinics and healthcare institutions, the entire chain of healthcare industry ecosystems is accelerating the closing cycle. In-house brand management company CEO, clinic operations president, Shenzhen shares topics around the standardized operations of in-house meeting rooms and clinics in In-house City, articulates standardized management processes and refines the two-way dynamics of customer operations, continuously improving the efficiency of healthcare services and user experience. For the general public, it is particularly important to establish a healthy concept of scientific reasoning.
In-depth collaboration between Inhealth and investment institutions provides solid capital support for cutting-edge technological research and development, clinical practice conversion landings and industrial scale expansion. Inhealth Group co-founder, medical president Zhang Yi, co-founder of Inhealth Group, clinic operations president, Ms. Shenzhen, capital empowerment level, from the strategic cooperation fund signing ceremony at the venue of the conference.
The most notable news of the entire conference was revealed at the press link: Jun Jun and Zhang Jun jointly announced that the integrated healthcare institution under Inhealth Medical is planned to officially open its operations in late October 2026. 03 The growth of the two-way China development enterprises based on contemporary developments in the soils of the focused industry, the progress of the industry is being driven jointly by market actors. With high-quality medical services, specialized medical institution management, full-chain branded operations as the core pillars, the business layout is highly aligned with the direction of national industry development, and nanotechnology is a key exploration of the nation's high-end medical device manufacturing, IgA anti-inflammatory innovation is a cutting-edge practice in the development of new biopharmaceuticals, and the two core outcomes accurately align the policy support pathway.
With the deepening of the Healthy China 2030 strategy, the biopharmaceutical industry is positioned as a national strategic emerging pillar industry, cell diagnostics, treatment of new types of antibiotics, and high-end medical devices are listed as key development directions. The effects of the industrial chain integration at the core of Inhealth are gradually manifesting: upstream technological R&D and medical devices, downstream clinical practice transformation and medical services, downstream city halls + clinics empowering health care, health management, accelerating the interconnection of all sectors, jointly promoting the improvement and upgrading of the industrial ecosystem. Deep farming development of enterprises will also reverse the upgrading of the industrial ecosystem.
The next step will be to use this new product conference as a new starting point, to rigorously define development strategies, to steadily advance technological research and development, to build medical institutions, to establish clinics, and to build a full-scale healthcare system. In the future, companies will continue to deepen industrial collaboration, focus technology breakthroughs, continue to perfectly cover R&D, clinical practices, rehabilitation of industrial ecosystems, improve the welfare of the masses and contribute to the strategic landing of healthy China. To encourage you to give more massages to children in the spring, please contact 9 of the top 10 most popular detoxification methods to control the human body.
A team of experts taught you science pre-warm up and fall dry up health care memories cleaning cleaning cleaning cleaning cleaning cleaning cleaning health workshops for new employment groups occupational health workshops in Beijing held a warm-hearted health service in Beijing right to the people's door in the city of Huangyang Street: Owl Dream Assistant Schools have made a breakthrough in Hamburg nationwide! In the first half of the year, China will promote the growth of the 6G industry in the first half of the year, which is equivalent to the continuation of the land market high-temperature zinc core city, China's international healthcare system is continuing to monitor the latest developments in the field of healthcare, to provide you with authority, reliable information and medical services. If you need further advice on the relevant content, welcome to contact authorized experts through the platform.
